The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Observational cohort randomized controlled study to study the influence of correction of ID
by intravenous injection of ferric carboxymaltose (Ferinject®) on quality of life indicators,
functional status in a cohort of patients with HFpEF.
Phase:
Phase 4
Details
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences